Clearbridge’s second batch of Sinopharm vaccines arrives in Singapore

The company’s first batch has been fully allocated in the country.

Clearbridge announced that the second batch of COVID-19 vaccines from Sinopharm has arrived in Singapore.

This development comes as the initial batch of vaccines from the company has been fully allocated in Singapore. These arrived on 28 August and were distributed by Medic Surgical & Laser Clinic, a subsidiary of the company.

The Royal Healthcare Specialists Center will also have access to this shipment under the Special Access Route approval from the Health Sciences Authority of Singapore.

Currently, the Sinopharm COVID-19 vaccine has been authorised for conditional and emergency use in several countries. These include the People’s Republic of China, the United Arab Emirates, Malaysia, Thailand, and Indonesia.

Join Singapore Business Review community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Module integration and completion are not part of its responsibilities.
The company says it will continue to welcome feedback from workers.
OneMap3D data from ERA will be incorporated into its RealtyWatch mobile apps
$500,000 was contributed to the library's Green Grove showcase.
He has over 25 years of experience in business and risk roles.
The country also won 'Best Seaport in Asia' for the 33rd time.
Flight bookings were made available on 22 October.
Sembcorp Industrialshowed the most growth.
Analysts said there are three factors that drove the price growth.
Prices of private residential properties rose by 1.1% in Q3, marking the sixth consecutive quarter of growth.
72% of Singaporeans were aware of the term 'ESG.'
This strong performance was due to the recent acquisitions by the company.